Relmada Therapeutics Cash Flow Statement (2012-2026) | RLMD

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-26.46M-42.65M-34.18M-38.30M-45.51M-38.74M-38.70M-26.95M-24.66M-21.37M-25.57M-21.93M-17.86M-22.15M-18.42M-17.78M-9.90M-10.08M-19.95M-18.50M
Depreciation and Depletion (Quarter)
452.00
Share-based Compensation (Quarter)
8.27M8.01M18.36M11.93M12.29M8.34M11.63M11.35M11.17M11.39M9.89M8.30M7.21M7.95M6.73M3.57M4.35M3.61M2.37M0.96M
Gains from Investment Securities (Quarter)
-0.12M1.51M0.46M0.22M0.02M0.74M-0.03M-0.67M0.16M0.17M-3.35M3.96M0.13M13.05M0.04M11.26M0.05M-0.08M-0.11M125.00
Non-cash Items (Quarter)
1.79M2.08M2.14M2.75M7.70M3.71M0.42M4.77M5.60M6.56M11.18M7.95M0.35M8.89M9.48M8.75M6.92M37.92M
Cash from Operations (Quarter)
-17.21M-20.92M-37.66M-19.43M-21.63M-26.86M-35.88M-16.51M-13.27M-11.63M-10.25M-13.04M-13.26M-16.66M-8.80M-18.07M-6.40M-6.72M-14.60M-15.07M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)
452.00-1.30M
Change in Working Capital
Change in Receivables (Quarter)
-0.51M
Change in Inventory (Quarter)
Change in Account Payables (Quarter)
2.37M2.25M-1.52M-0.52M3.22M-3.47M1.19M-0.84M0.43M-2.00M0.65M1.68M-1.01M-1.83M1.79M-2.87M0.10M0.09M0.12M1.76M
Change in Accured Expenses (Quarter)
-1.18M2.08M-1.67M0.87M6.64M-1.03M-3.14M-1.53M0.17M-0.28M3.12M-1.52M-1.81M0.38M0.42M-2.19M-0.19M-0.04M1.13M-1.56M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)
30.30M53.12M49.32M15.89M7.36M37.14M6.65M74.77M9.66M15.43M41.05M17.07M15.31M19.26M12.00M15.85M7.00M6.99M5.86M14.29M
Cash from Investing Activities (Quarter)
-5.91M27.51M-91.18M-10.03M-0.14M31.56M-1.66M40.00M-1.15M3.86M7.74M10.06M14.01M16.14M11.35M15.36M6.68M6.75M-76.93M-135.23M
Financing Activities
Other financing activities (Quarter)
11.93M12.30M8.34M-77.51M11.35M11.17M11.39M-33.82M0.03M0.09M0.17M0.07M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Long-Term Debt Repayments (Quarter)
Short-Term Debt issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
22.00M-0.04M161.23M0.30M42.43M-42.02M0.56M0.25M160.00M
Shares Repurchased (Quarter)
3.36M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
23.99M0.19M161.84M29.95M14.09M0.57M0.41M0.22M-0.09M-0.17M93.64M156.57M
Change in Cash (Quarter)
0.87M6.78M32.99M0.49M-7.67M5.26M-37.13M23.50M-14.43M-7.77M-2.61M-2.76M0.75M-0.60M2.37M-2.71M0.20M0.03M2.11M6.28M
Free Cash Flow (Quarter)
-17.21M-20.92M-37.66M-19.43M-21.63M-26.86M-35.88M-16.51M-13.27M-11.63M-10.25M-13.04M-13.26M-16.66M-8.80M-18.07M-6.40M-6.72M-14.60M-15.07M
Net Cash Flow (Quarter)
0.87M6.78M32.99M0.49M-7.67M5.26M-37.13M23.50M-14.43M-7.77M-2.51M-2.76M0.75M-0.60M2.37M-2.71M0.28M0.03M2.11M6.28M